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Measles is a highly contagious vaccine-preventable disease that results from infection with measles virus and is still responsible for >100,000 deaths every year, 
down from >2 million deaths annually before the introduction and 
widespread use of measles vaccine. Every year in India, nearly 
2.7 million children get measles. Those, who survive, suffer 
from serious complications including diarrhea, pneumonia, and 
malnutrition. To ensure protection against the vaccine-preventable 
diseases, the health ministry has initiated a Measles-Rubella (MR) 
vaccination campaign in the nation. However, only 63% of the 
member states of the World Health Organization (WHO) have met 
the target of immunizing at least 90% of children with measles first 
dose, while <50% of the world’s children have been immunized 
with the globally recommended second dose of the vaccine [1-6].
Recently, changing trends in the occurrence measles are 
noted like incidence in younger infants and in those who have 
received measles vaccine. Furthermore, measles infection of 
immunocompromised individuals may not result in typical measles 
symptoms. Therefore, the current measles elimination goals in all 
the WHO regions necessitate case-based surveillance including 
laboratory confirmation of suspect cases. With coordination from 
the WHO, the Global MR Laboratory Network performs case-
based laboratory surveillance using standardized methods. The 
WHO case definition for measles requires the presence of acute 
febrile disease (≥38.3°C) featuring a generalized maculopapular 
rash lasting 3 days or longer, and coryza, cough, or conjunctivitis. 
A suspected case meets the case definition with attendant suspicion 
of measles by the examining clinician. A laboratory-confirmed 
case meets these clinical criteria, along with the laboratory 
confirmation of infection, typically by detection of MeV-specific 
immunoglobulin M (IgM) antibodies in serum or by detection 
of viral RNA by reverse transcription-polymerase chain reaction 
(RT-PCR). In addition, serological techniques play an important 
role in the evaluation of population immunity [7-15].
The measles vaccine coverage was just 56% in 2000 
and increased to 87% in 2015. The National Family Health 
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Survey-4 (2015–2016) has assessed it to be 81.1%. This is low 
compared to the 95% coverage level required for elimination. In 
addition, the coverage is unevenly distributed in different states in 
India. India still accounts for a significant proportion (estimated 
to be over 36%) of measles-related deaths in children [8]. India 
achieved an estimated 51% reduction in mortality (2000–2015) 
as compared to that achieved in African (85%), Western Pacific 
(80%), and European (79%) regions and in South-East Asian 
region excluding India (91%). However, the pace of this progress 
will have to be greatly enhanced, if our country has to eliminate 
measles by 2020 [16-20].
Measles continues to remain a significant public health 
challenge in India [21-22]. India accounts for maximum measles-
related mortality worldwide. Hence, this study regarding the 
clinical and laboratory profile of children with measles is relevant.
MATERIALS AND METHODS
This study was done in the Department of Pediatrics, SAT 
Hospital, Govt. Medical College, Thiruvananthapuram, over a 
period of 2 years. Ethics clearance for the study was obtained from 
the Institutional Ethics Committee, and informed consent was 
obtained from the parents of each participant. Consecutive cases 
of clinically diagnosed measles in children up to 12 years were 
recruited for the study. Detailed history and physical examination 
were done. From each study participant, 4 ml blood was collected 
for routine investigations and serological tests for diagnosis of 
measles. Throat/nasopharyngeal sample was obtained as soon 
as possible after admission for PCR and measles-specific IgM 
ELISA assays.
Measles IgM ELISA was carried using a commercially 
available measles IgM ELISA kit (IBL International, Germany). 
Test results were interpreted as IgM ELISA reactive, non-
reactive, or borderline. Measles RT-PCR assay was performed on 
RNA isolated from throat/nasopharyngeal samples by an in-house 
measles N-gene based RT-PCR assay which amplifies a 600 
nucleotide length region of measles genome. Amplicons were run 
on agarose gel and read on a Gel Doc instrument. Results were 
reported as either measles virus RNA detected or not detected. 
Measles IgM ELISA and measles RT-PCR assay were carried out 
at Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, 
Kerala, India. Laboratory proven (PCR/IgM ELISA Positive or 
both) cases of measles were taken for analysis. Data were entered 
in Microsoft Excel sheet. Completeness was checked. The 
analysis was done using statistical software SPSS.
RESULTS
Of 173 clinically diagnosed cases, 149 laboratory confirmed 
cases by RT-PCR, ELISA, or both were taken for analysis. 
Considering the age distribution, the mean age was 13 months. 
High incidence was noted in infants (62%), and 70 (47%) of cases 
were <9 months of age. 3 (2%) of the total cases were <28 days 
of age. 36 (24.16%) of cases were aged between 9 months and 
5 years, 24 (16.1%) were aged 5–10 years, and 19 (12.75%) were 
>10 years of age. Regarding gender distribution, 53% were male 
children and 47% were female with male:female ratio of 1.13:1.
Regarding the immunization status of the study participants, 
47% of cases were <9 months of age and were not eligible for 
measles vaccine according to the National Immunization Schedule. 
Among children eligible for immunization (>9 months), 24.8% 
were unimmunized, 16.77% were immunized with single dose, 
and 8.72% had 2 doses of measles vaccine. Among the cases with 
measles, 25% had measles vaccine.
Regarding the nutritional status, 38.9% of cases were 
undernourished and 35.6% of cases had contact with measles. 
Following complications were seen in cases: bronchopneumonia 
(76.5%), diarrhea (24.16%), laryngotracheobronchitis (11.4%), 
and otitis media (2.68%). As per the Kuppuswamy’s scale of 
socioeconomic status (SES), 59.7% were from SES 4, 35.6% 
from SES 3, and 4.7% belonged to SES 2. Of 149 cases, 53% 
(n=79) needed hospital stay <5 days and 47% (n=70) had hospital 
stay >5 days. More frequency of prolonged hospital stay due 
to complications was noted among unimmunized children. 
Statistically significant difference was noted regarding the 
duration of hospital stay among immunized and non-immunized 
children (p=0.006).
Mortality was 0.67% (n=1) due to sepsis, myocarditis, and 
shock in a young infant with measles. Regarding the laboratory 
profile, mean Hb was 10.5 g/dl and mean leukocyte count was 
7993/mm3. Among immunized children with measles confirmed 
by PCR, measles-specific IgM response was reactive in 36.4% 
cases, borderline in 39.4%, and non-reactive in 24.2% cases. 
In the early phase of measles (within 3 days of onset of rashes) 
that were confirmed by PCR, IgM response was found to be 
inconclusive or non-reactive in 60% cases. Seasonal pattern was 
noted in the incidence of measles, and high incidence was noted 
during the month of January to May and August to September.
DISCUSSION
Measles continues to be a major public health challenge despite 
the availability of a safe and effective vaccine. There are no animal 
or environmental reservoirs for measles [1]. In line with the 
WHO goal for accelerated measles control, it is important to have 
accurate data on epidemiology of measles in different geographic 
regions of the country. In the present study, we studied the clinical 
and laboratory profile of children admitted with measles over a 
period of 2 years in our hospital. Furthermore, the usefulness of 
RT-PCR is evaluated and measles-specific IgM response is noted. 
Of 173 clinically diagnosed cases of measles, 149 laboratory 
confirmed cases by RT-PCR or ELISA or both were included for 
analysis and studied.
In this study, high incidence of measles was noted in infants 
(62%). Another important finding was that 47% of the cases 
were below 9 months of age including newborns (2.01%). 
Incidence noted in infants in this study is high compared to the 
previous reports [1-4]. After the introduction of measles vaccine, 
the increasing incidence in younger age group is reported in 
many studies [5,6]. High incidence of measles in infants is also 
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reported in the study done by Indwar et al. at West Bengal [9]. 
High incidence in children <9 months of age noted in this study 
should be given due consideration and measures should be taken 
to protect these children from the measles infection and the 
age of administration of measles vaccine may be reconsidered. 
Furthermore, maternal health, immune status, and maternally 
transmitted antibody levels should be given due consideration.
Among eligible children for immunization, 24.8% were 
unimmunized, 16.77% were immunized with single dose, and 
8.72% had 2 doses of measles vaccine. Similarly, in a study by 
Lawrence et al., 54.3% of cases of measles were unimmunized [5]. 
Therefore, it is essential to stress on the measles immunization 
coverage. Among the cases, 25% had received the measles 
vaccine and this is in accordance with the study by Lawrence 
et al. where the incidence of measles was noted in 28.6% of 
the immunized children [5]. This indicates that the factors 
affecting vaccine efficacy should be given due consideration. 
The NFHS-4 (2015–2016) has reported that the measles vaccine 
coverage in India was 81.1% [7]. This is low compared to the 
95% coverage level required for elimination of measles [8].
The mortality noted in our study was 0.67%. It was an infant 
with measles complicated by sepsis, myocarditis, and shock. In 
the study done by Indwar et al. at Kolkatta, West Bengal, age-
specific case fatality rate of children admitted with measles in a 
tertiary care center was found to be 17% in children <5 months, 
7% in 6–8 months, 5% in 9 months to 1 year, 3% in children of 
2–5 years, 0.7% in 6–10 years, and 0 in children of >10 years of 
age. The most common cause of death was very severe pneumonia 
and respiratory failure [9].
Regarding gender distribution, 53% were male children and 
47% were female with slight male dominance. The same results 
were observed in other studies also. 59.7% of the cases were 
from SES 4 and 35.6% were from SES 3 which are supported by 
the previous evidence suggesting higher incidence of measles in 
children of low-socioeconomic background [10-14]. The seasonal 
pattern in measles incidence is noted in our study. Same finding 
was noted in other studies also [13,14]. In our study, 38.9% of 
cases were undernourished. Undernutrition is reported as a risk 
factor for measles virus infection and complications in other 
studies also [6,16,17]. Pneumonia was the major complication 
(76.5%). Same observation was noted in other studies also [17].
Considering the laboratory tests for confirmation in this study, 
RT-PCR was found to be particularly useful for early diagnosis 
of measles and for diagnosis of measles in children who have 
received the measles vaccine. Depending on geography and 
seasonality, the clinical presentation of measles may mimic 
those of other viral diseases. Furthermore, measles infection 
of immunocompromised individuals may not result in typical 
measles symptoms. Therefore, the current measles elimination 
goals in all the WHO regions necessitate case-based surveillance 
including laboratory confirmation of suspect cases [18]. Molecular 
surveillance in combination with standard epidemiologic 
information can be used to trace pathways of transmission and to 
provide evidence for verification of measles elimination. Although 
detection of viral RNA by RT-PCR is playing an increasing role 
in case confirmation, IgM detection by enzyme immunoassay 
is still the most commonly used diagnostic method. In addition, 
serological techniques play an important role in the evaluation 
of population immunity. Despite the genotypic diversity, measles 
virus has only one serotype. Genetic stability of measles virus 
is exceptionally good. Because of the availability of a highly 
effective and relatively inexpensive vaccine, the monotypic 
nature of the virus and the lack of an animal reservoir, measles 
is considered eradicable [18-20,23-25]. Our study has certain 
limitations and results may vary from the actual community data 
as this study was done in a tertiary care setting.
CONCLUSION
The incidence of measles in fairly good number of children 
(47%) below 9 months including the newborns is highlighted 
in this study. This finding indicates the need for considering 
immunization in children <9 months of age. About 24.83% of 
children were not immunized with measles vaccine; therefore, 
measles vaccine coverage should be stressed. Among cases, 
25% had prior measles vaccination, so factors affecting vaccine 
efficacy should be given due consideration. RT-PCR was found 
to be particularly useful for early diagnosis of measles and in 
immunized children.
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